Advanced Endoscopy During COVID-19

NCT ID: NCT04385147

Last Updated: 2020-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

670 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-18

Study Completion Date

2020-07-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.

evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit.

Target audience:

\- Physicians performing advanced gastrointestinal endoscopies in different countries.

Objectives:

* Primary objective:

1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details.
* Secondary objectives:

1. Effect of COVID-19 precautions on procedure time, procedure success, complications and patient outcomes
2. Effect of COVID-19 on working time and staff number

Process:

A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholangitis, Secondary Biliary Cholangiocarcinoma Obstructive Jaundice Pancreas Cancer COVID-19 SARS-CoV-2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ERCP

Patients who will have endoscopic retrograde cholangiopancreatography

Endoscopic management according to standard of care

Intervention Type OTHER

Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case

EUS

Patients who will have endoscopic ultrasound

Endoscopic management according to standard of care

Intervention Type OTHER

Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic management according to standard of care

Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred for ERCP or EUS during the study period

Exclusion Criteria

* Patients refusing to participate in the study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helwan University

OTHER

Sponsor Role collaborator

National Liver Institute, Egypt

OTHER

Sponsor Role collaborator

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Alboraie

Lecturer of medicine and gastroenterology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kings County Hospital Center, Brooklyn, NY, USA

Albertson, New York, United States

Site Status

Al-Azhar Univerisity

Cairo, , Egypt

Site Status

University Medicine Greifswald

Greifswald, , Germany

Site Status

2- Hospital Guillermo Kaelin De la Fuente - EsSalud

Lima, , Peru

Site Status

Singapore General Hospital

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Egypt Germany Peru Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Global-Endo-COVID

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.